APA (7th ed.) Citation

Zhou, C., Wang, B., Teng, C., Yang, H., Piha-Paul, S. A., Richardson, G., . . . Lemech, C. (2025). A phase Ia study of a novel anti-HER2 antibody–drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-024-05985-z

Chicago Style (17th ed.) Citation

Zhou, Chenfei, et al. "A Phase Ia Study of a Novel Anti-HER2 Antibody–drug Conjugate GQ1001 in Patients with Previously Treated HER2 Positive Advanced Solid Tumors." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-024-05985-z.

MLA (9th ed.) Citation

Zhou, Chenfei, et al. "A Phase Ia Study of a Novel Anti-HER2 Antibody–drug Conjugate GQ1001 in Patients with Previously Treated HER2 Positive Advanced Solid Tumors." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-024-05985-z.